Merck's EMEA Advance Biotech Grant at BIO-Europe
Take your company to new heights with Merck's EMEA Advance Biotech Grant Program
Through their EMEA Advance Biotech Grant Program, Merck recognizes stand-out emerging biotech companies and helps them navigate their path to commercialization. Delivered as a dynamic challenge, five selected biotech companies will have the opportunity to present their breakthroughs to Merck's Grant representatives and the overall BIO-Europe audience.
Congratulations to the selected finalists
Merck's EMEA Advanced Biotech Grant will take place Monday, November 3, 2025 at 17:30 in Room 2
About Merck's EMEA Advance Biotech Grant
Merck understands the challenges emerging biotech companies face in the quest to push the next generation of drugs to market. This is why they have developed the Advance Biotech Grant programs which occurs on regular basis in different regions of the world. These programs award grant recipients with products, services and consultation support to advance production and help accelerate their path to commercialization.
Meet the finalists
Term and Conditions
Please review Merck's Terms and Conditions here.